Home › Funds › KINGDON CAPITAL MANAGEMENT, L.L.C. › ZVRA

KINGDON CAPITAL MANAGEMENT, L.L.C. position in ZVRA

ZEVRA THERAPEUTICS INC · Health Care

KINGDON CAPITAL MANAGEMENT, L.L.C. reported holding 775,000 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 1.22% of its reported portfolio and ranking #29 among its reported holdings. KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed ZVRA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)775.00K sh
Reported value held$11.11M
Portfolio Weight1.22%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KINGDON CAPITAL MANAGEMENT, L.L.C.'s ZVRA position evolved

KINGDON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in ZVRA in Q2 2025 at 450,000 shares (US$4.0M). The position peaked in Q2 2026 at 775,000 shares, worth US$11.1M. Across 5 filings, KINGDON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 775,000 shares valued at US$11.1M. Notable position changes include a 44% increase in Q3 2025 (shares fell 6% over the following quarter), a 32% increase in Q1 2026 (shares rose 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 450.00K $3.96M New
Q3 2025 650.00K $6.18M Add
Q4 2025 585.07K $5.24M Reduce
Q1 2026 775.00K $7.22M Add
Q2 2026 775.00K $11.11M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZVRA and 13F data

ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), Retirement Planning Co of New England, Inc. (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZVRA

All ZVRA fund holders →

FAQ

How long has KINGDON CAPITAL MANAGEMENT, L.L.C. held ZVRA?

KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed ZVRA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is KINGDON CAPITAL MANAGEMENT, L.L.C.'s current position in ZVRA?

As of Q2 2026, KINGDON CAPITAL MANAGEMENT, L.L.C. holds 775.00K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $11.11M, representing 1.22% of its reported portfolio and ranking #29.

Has KINGDON CAPITAL MANAGEMENT, L.L.C. been buying or selling ZVRA?

In the latest 13F filing (Q2 2026), KINGDON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in ZVRA. The position peaked in Q2 2026 at 775.00K shares.

Which other funds hold ZVRA?

Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, Retirement Planning Co of New England, Inc., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.